A-Cube
Announcement of Exhibition at BioJapan 2025
Exhibition Information ProteoBridge Inc. will exhi…
A-Cube Index
A-Cube
Notice of Exhibition at JACLaS EXPO 2025
Exhibition Information ProteoBridge Inc. will be e…
A-Cube
Announcement of Exhibition at the 33rd Annual Meeting of the Japan Sjögren’s Syndrome Society (Ongoing)
The 33rd Annual Meeting of the Japan Sjögren’s Syn…
A-Cube
34th A-Cube® Research Test Seminar Announcement
The 34th A-Cube® Research Test Seminar will be hel…
A-Cube
Our Technology Featured in Allergy & Rheumatic Diseases September 2025 Issue – Special Feature on “Allergen Immunotherapy”
In the September 2025 issue of Allergy & Rheum…
A-Cube
🎉 The 11th Annual Meeting of the Japanese Society of Myology Has Officially Begun!
At our booth, we are showcasing a wide range of se…
A-Cube
[New Service Announcement] Launch of Paraneoplastic Neurological Syndrome-Related Antibody Detection Set (Research Use Only)
~ Cutting-edge technology enables simultaneous tes…
A-Cube
The 66th Annual Meeting of the Japanese Society of Neurology has begun! We are introducing HuPEX and many other services at our booth.
At our booth, we will introduce the features of ea…
A-Cube
Exhibiting at the 66th Annual Meeting of the Japanese Society of Neurology
Proteobridge Inc. (Headquarters: Tokyo, President …
A-Cube
A paper using A-Cube® was published in the international academic journal in the field of dermatology, “The Journal of Dermatology.”
In this paper, we developed a Japanese version of …